scholarly article | Q13442814 |
P50 | author | Friedemann Paul | Q30353016 |
Juliane Klehmet | Q56956565 | ||
P2093 | author name string | Andreas Meisel | |
Ralf Reilmann | |||
Alexander U Brandt | |||
Sarah Hoffmann | |||
Matthias Dornauer | |||
Svenja Beutner | |||
P2860 | cites work | Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data | Q30624346 |
Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies | Q33183443 | ||
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data | Q33489152 | ||
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe | Q34619228 | ||
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study | Q35877852 | ||
Advances in the diagnosis, pathogenesis and treatment of CIDP. | Q37918316 | ||
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options | Q38121471 | ||
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies | Q38224784 | ||
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar | Q38991068 | ||
CIDP diagnostic pitfalls and perception of treatment benefit | Q40730855 | ||
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. | Q43708051 | ||
Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome | Q44643471 | ||
Coordination of prehensile forces during precision grip in Huntington's disease. | Q45300253 | ||
Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures | Q45303227 | ||
Objective assessment of progression in Huntington's disease: a 3-year follow-up study. | Q45303848 | ||
A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease | Q45304326 | ||
Motor outcome measures in Huntington disease clinical trials | Q45304469 | ||
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study | Q46570822 | ||
Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. | Q51201708 | ||
Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy. | Q55284498 | ||
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database | Q57294928 | ||
The vigorimeter: for measurement of the strength of the hand and simulation testing | Q67219007 | ||
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study | Q67228612 | ||
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial | Q80454073 | ||
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice | Q83100152 | ||
Does grip strength reflect isokinetic muscle strength in lower limbs in patients with chronic inflammatory demyelinating polyneuropathy? | Q88230626 | ||
Ultrastructural mechanisms of macrophage-induced demyelination in CIDP | Q93079381 | ||
P433 | issue | 1 | |
P304 | page(s) | 118 | |
P577 | publication date | 2019-06-08 | |
P1433 | published in | BMC Neurology | Q15763734 |
P1476 | title | Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy. | |
P478 | volume | 19 |